Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-17

FDA Approved: FLURAZEPAM HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for Flurazepam hydrochloride from Chartwell RX, LLC, indicating continued approval of this generic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flurazepam hydrochloride (Flurazepam hydrochloride)

Snippet

SUPPL AP for FLURAZEPAM HYDROCHLORIDE (FLURAZEPAM HYDROCHLORIDE)